Stock Events

Stock Events

Revelation Biosciences 

$1
19
+$0.02+1.63% Today

Statistics

Day High
1.03
Day Low
0.96
52W High
37.68
52W Low
0.96
Volume
93,410
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
-20.64
-14.04
-7.43
-0.83
Expected EPS
-0.83
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-15.04MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow REVB. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap19.46B
Moderna is a leader in mRNA technology, competing in the biotech space with innovative treatments and vaccines that could overlap with Revelation Biosciences' therapeutic areas.
BioNTech
BNTX
Mkt Cap22.65B
BioNTech competes in the development of novel therapies and vaccines, directly challenging Revelation Biosciences in the innovative biopharmaceutical market.
Novavax
NVAX
Mkt Cap1.49B
Novavax is involved in the development of vaccines for infectious diseases, competing with Revelation Biosciences in the vaccine development space.
Pfizer
PFE
Mkt Cap144.37B
Pfizer is a large pharmaceutical company with a broad product portfolio that includes vaccines and therapies, competing across several of Revelation Biosciences' potential markets.
Johnson & Johnson
JNJ
Mkt Cap545.74B
Johnson & Johnson, through its pharmaceutical division Janssen, competes in the development of drugs and vaccines, covering areas that Revelation Biosciences may target.
Gilead Sciences
GILD
Mkt Cap160.88B
Gilead Sciences is known for its antiviral drugs, directly competing with Revelation Biosciences in the development of treatments for infectious diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.2B
Regeneron Pharmaceuticals competes in the biotechnology field, focusing on immunology and infectious diseases, areas of interest for Revelation Biosciences.
Vertex Pharmaceuticals
VRTX
Mkt Cap110.9B
Vertex Pharmaceuticals focuses on creating new treatments for serious diseases, potentially competing with Revelation Biosciences in drug development and innovation.
AMGEN
AMGN
Mkt Cap176.21B
Amgen is a biotech firm that develops innovative medicines, including for immune disorders, competing with Revelation Biosciences in the biopharmaceutical sector.
Astrazeneca
AZN
Mkt Cap281.6B
AstraZeneca is a global pharmaceutical company that develops vaccines and treatments for various diseases, competing with Revelation Biosciences in several therapeutic areas.

About

Revelation Biosciences, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was formerly known as Petra Acquisition, Inc. and changed its name to Revelation Biosciences, Inc. in January 2022. Revelation Biosciences, Inc. was incorporated in 2019 and is based in San Diego, California.
Show more...
CEO
Mr. James M. Rolke
Employees
8
Country
United States
ISIN
US76135L8046

Listings

STU
DE
56U0.STU
XNAS
US
REVB
XNAS
US
REVBW
BOATS
BOATS
REVB.BOATS

0 Comments

Share your thoughts

FAQ

What is Revelation Biosciences stock price today?▼
The current price of REVB is $1 USD — it has increased by +1.63% in the past 24 hours. Watch Revelation Biosciences stock price performance more closely on the chart.
What is Revelation Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Revelation Biosciences stocks are traded under the ticker REVB.
Is Revelation Biosciences stock price growing?▼
REVB stock has risen by +2.73% compared to the previous week, the month change is a -12.23% fall, over the last year Revelation Biosciences has showed a -97.25% decrease.
When is the next Revelation Biosciences earnings date?▼
Revelation Biosciences is going to release the next earnings report on August 07, 2026.
What were Revelation Biosciences earnings last quarter?▼
REVB earnings for the last quarter are -2.71 USD per share, whereas the estimation was -2.71 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Revelation Biosciences revenue for the last year?▼
Revelation Biosciences revenue for the last year amounts to 0 USD.
What is Revelation Biosciences net income for the last year?▼
REVB net income for the last year is -15.04M USD.
How many employees does Revelation Biosciences have?▼
As of May 18, 2026, the company has 8 employees.
In which sector is Revelation Biosciences located?▼
Revelation Biosciences operates in the Health & Wellness sector.
When did Revelation Biosciences complete a stock split?▼
The last stock split for Revelation Biosciences was on January 28, 2026 with a ratio of 1:4.
Where is Revelation Biosciences headquartered?▼
Revelation Biosciences is headquartered in San Diego, United States.